Evidence map›Paper›PMID 32117775›Full record

ArticleFrontiers in oncology2020

The Rare Variant rs35356162 in

Junlong Wu, Meilin Wang, Haitao Chen, Jianfeng Xu, Guiming Zhang, Chengyuan Gu, Qiang Ding, Qingyi Wei, Yao Zhu, Dingwei Ye

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Junlong WuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Meilin WangDepartment of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China.
Haitao ChenState Key Laboratory of Organ Failure Research, Guangdong Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jianfeng XuFudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Guiming ZhangDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chengyuan GuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Qiang DingFudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Qingyi WeiCancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
Yao ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fudan University Shanghai Cancer Center · CNFudan University · CNDuke Medical Center · USNanjing Medical University · CNQingdao University · CNShanghai Medical College of Fudan University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancerChineseexome arraysingle nucleotide variantUHRF1BP1

Identifiers

PMID32117775
PMCPMC7026461
OpenAlexW3006657960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.